The concentration of u-PA and PAI-1 antigen in tissue extracts of nasopharyngeal carcinoma

European Archives of Oto-Rhino-Laryngology

Volumn 254, Issue 6, 1997, Pages 277-280

  Sunagawa, M ^a   Huang, G W ^b   Nakamura, M ^a   Kosugi, T ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Nasopharyngeal carcinoma; Plasminogen activator inhibitor 1; Tumor invasion; Urokinase type plasminogen activator

Indexed keywords

ANTIPLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE;

ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; TISSUE LEVEL;

EID: 0030757370     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02905987     Document Type: Article

References (13)

1. Carrell RW, Boswell DR (1986) Serpins: the superfamily of plasma proteinase inhibitors. In: Barrett A, Salvesen S, (eds) Proteinase inhibitors. Elsevier, Amsterdam, pp 403-420
2. Danø K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L (1985) Plasminogen activators tissue degradation, and cancer. Adv Cancer Res 44:139-266
3. Kosugi T, Huang G-W, Nakamura M, Koja S, Nong H-T (1990) Identification of a plasminogen activator derived from nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol 247: 374-378
4. Lowry OH, Rosenbrough NJ, Farr AL, Randall JR (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-295
5. Markus G, Camiolo SM, Kohga S, Madeja JM, Mittelman A (1983) Plasminogen activator secretion of human tumor in short-term organ culture, including a comparison of primary and metastatic colon tumors. Cancer Res 43:5517-5525
6. Nagayama M, Sato A, Hayakawa H, Urano T, Takada Y, Takada A (1994) Plasminogen activators and their inhibitors non-small cell lung cancer: low content of type 2 palsminogen activator inhibitors associated with tumor dissemination. Cancer 73:1398-1405
7. Nishino N, Aoki K, Tokura Y, Sakaguchi S, Takada Y, Takada A (1988) The urokinase type of plasminogen activator in cancer of digestive tract. Thromb Res 50:527-535
8. Pappot H, Gårdsvoll H, Rømer J, Pedersen AN, Grøndahl-Hansen J, Pyke J, Brünner N (1995) Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications. Biol Chem Hoppe-Seyler 376:259-267
9. Saksela O, Rifkin DB (1988) Cell-associated plasminogen activator: regulation and physiological function. Annu Rev Cell Biol 4:93-126
10. Schwab W, Clasen B, Steinhoff H-J (1987) Neue und geänderte Richtlinien zum TNM-System im Kopf-Hals-Bereich. HNO 35:112-118
11. Sumiyoshi K, Baba S, Sakaguchi S, Urano T, Takada Y, Takada A (1991) Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitor in human breast cancer: possible roles in tumor progression and metastasis. Thromb Res 63:59-71
12. Vassalli J-D, Sapppino A-P, Belin D (1991) The plasminogen activator/plasmin system. J Clin Invest 88:1067-1072
13. Wiman B, Almquist Å, Sigurdardottir O, Lindahl T (1988) Plasminogen activator inhibitor 1 (PAI-1) is bound to vitro-nectin in plasma. FEBS Lett 242:125-128